Category Added in a WPeMatico Campaign
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a clinical-stage biopharmaceutical company, announced today the Investigational New Drug (IND) clearance of its Bruton’s...
Connecting Trade Demands in North America with Quality Products Virtually BEIJING--(BUSINESS WIRE)--Organized by DHgate, China’s leading B2B cross-border e-commerce marketplace,...
The last "Getter Robot" by Ken Ishikawa is going through an era of stagnation and chaos! TOKYO--(BUSINESS WIRE)--The hit manga...
Deeper Network is a startup bridging the gap to the future of Web 3.0 SANTA CLARA, Calif.--(BUSINESS WIRE)--Deeper Network, a...
KINGSTOWN, St. Vincent and the Grenadines--(BUSINESS WIRE)--Today (November 1), on behalf of Bitterz LLC (Hinds Building, Kingstown, St. Vincent and...
NEW YORK--(BUSINESS WIRE)--From October 16th - 17th in Zhumadian, the 7th International Forum on Industry and Education (IFIE) happened, hosted...
BANGKOK--(BUSINESS WIRE)--#AutoPartsExpo--The pandemic has created an environment where businesses need to be innovative to meet the challenges of the new...
DUBLIN--(BUSINESS WIRE)--The "Interior Architectural Coatings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher...
LONDON--(BUSINESS WIRE)--AM Best has revised the outlooks to stable from positive and affirmed the Financial Strength Rating of B+ (Good)...
SAN JOSE, Calif. & HYDERABAD, India--(BUSINESS WIRE)--#Analytics--Analytics Insight has announced 'The 10 Most Innovative Big Data Analytics Companies 2020' in...
HONG KONG--(BUSINESS WIRE)--AM Best has assigned a Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of...
VILAYAT, GUJARAT, India--(BUSINESS WIRE)--#AshirvadPipes--To meet growing demand for chlorinated polyvinyl chloride (CPVC) pipe and fittings in India, Lubrizol Advanced Materials,...
SINGAPORE--(BUSINESS WIRE)--AM Best has revised the outlooks to stable from negative and affirmed the Financial Strength Rating of A- (Excellent)...
Ocular Therapeutix to receive $12 million upfront fee and development and commercialization milestones and other payments of up to $91...
Activities will support the clinical development of Rugen’s potential first-in-class, orally administered drug candidate with initial clinical focus on treatment-resistant...
